129 related articles for article (PubMed ID: 12480736)
21. Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1.
Buckwalter MS; Coleman BS; Buttini M; Barbour R; Schenk D; Games D; Seubert P; Wyss-Coray T
J Neurosci; 2006 Nov; 26(44):11437-41. PubMed ID: 17079673
[TBL] [Abstract][Full Text] [Related]
22. Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease.
Beckmann N; Schuler A; Mueggler T; Meyer EP; Wiederhold KH; Staufenbiel M; Krucker T
J Neurosci; 2003 Sep; 23(24):8453-9. PubMed ID: 13679413
[TBL] [Abstract][Full Text] [Related]
23. Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP.
Faraco G; Park L; Zhou P; Luo W; Paul SM; Anrather J; Iadecola C
J Cereb Blood Flow Metab; 2016 Jan; 36(1):241-52. PubMed ID: 25920959
[TBL] [Abstract][Full Text] [Related]
24. Functional role of TGF beta in Alzheimer's disease microvascular injury: lessons from transgenic mice.
Masliah E; Ho G; Wyss-Coray T
Neurochem Int; 2001; 39(5-6):393-400. PubMed ID: 11578774
[TBL] [Abstract][Full Text] [Related]
25. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances.
Thal DR; Capetillo-Zarate E; Larionov S; Staufenbiel M; Zurbruegg S; Beckmann N
Neurobiol Aging; 2009 Dec; 30(12):1936-48. PubMed ID: 18359131
[TBL] [Abstract][Full Text] [Related]
26. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy.
Shin HK; Jones PB; Garcia-Alloza M; Borrelli L; Greenberg SM; Bacskai BJ; Frosch MP; Hyman BT; Moskowitz MA; Ayata C
Brain; 2007 Sep; 130(Pt 9):2310-9. PubMed ID: 17638859
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model.
Lifshitz V; Weiss R; Benromano T; Kfir E; Blumenfeld-Katzir T; Tempel-Brami C; Assaf Y; Xia W; Wyss-Coray T; Weiner HL; Frenkel D
Neurobiol Aging; 2012 Feb; 33(2):432.e1-432.e13. PubMed ID: 21371785
[TBL] [Abstract][Full Text] [Related]
28. TGF-beta1 is increased in a transgenic mouse model of familial Alzheimer's disease and causes neuronal apoptosis.
Salins P; He Y; Olson K; Glazner G; Kashour T; Amara F
Neurosci Lett; 2008 Jan; 430(1):81-6. PubMed ID: 18063474
[TBL] [Abstract][Full Text] [Related]
29. Chronic cerebral hypoperfusion alters amyloid-β peptide pools leading to cerebral amyloid angiopathy, microinfarcts and haemorrhages in Tg-SwDI mice.
Salvadores N; Searcy JL; Holland PR; Horsburgh K
Clin Sci (Lond); 2017 Aug; 131(16):2109-2123. PubMed ID: 28667120
[TBL] [Abstract][Full Text] [Related]
30. Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology.
Papadopoulos P; Rosa-Neto P; Rochford J; Hamel E
PLoS One; 2013; 8(7):e68612. PubMed ID: 23874687
[TBL] [Abstract][Full Text] [Related]
31. Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease.
Zetterberg H; Andreasen N; Blennow K
Neurosci Lett; 2004 Sep; 367(2):194-6. PubMed ID: 15331151
[TBL] [Abstract][Full Text] [Related]
32. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice.
Wyss-Coray T; Yan F; Lin AH; Lambris JD; Alexander JJ; Quigg RJ; Masliah E
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10837-42. PubMed ID: 12119423
[TBL] [Abstract][Full Text] [Related]
33. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
34. Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's disease.
Lai AY; Dorr A; Thomason LA; Koletar MM; Sled JG; Stefanovic B; McLaurin J
Brain; 2015 Apr; 138(Pt 4):1046-58. PubMed ID: 25688079
[TBL] [Abstract][Full Text] [Related]
35. High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease.
Taheri S; Yu J; Zhu H; Kindy MS
J Alzheimers Dis; 2016 Oct; 54(3):1061-1072. PubMed ID: 27567835
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways.
Ongali B; Nicolakakis N; Tong XK; Lecrux C; Imboden H; Hamel E
Can J Physiol Pharmacol; 2018 May; 96(5):527-534. PubMed ID: 29505736
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
38. Scavenger receptor A deficiency accelerates cerebrovascular amyloidosis in an animal model.
Lifshitz V; Weiss R; Levy H; Frenkel D
J Mol Neurosci; 2013 May; 50(1):198-203. PubMed ID: 23108486
[TBL] [Abstract][Full Text] [Related]
39. Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice.
Niwa K; Carlson GA; Iadecola C
J Cereb Blood Flow Metab; 2000 Dec; 20(12):1659-68. PubMed ID: 11129782
[TBL] [Abstract][Full Text] [Related]
40. Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy.
Park L; Koizumi K; El Jamal S; Zhou P; Previti ML; Van Nostrand WE; Carlson G; Iadecola C
Stroke; 2014 Jun; 45(6):1815-21. PubMed ID: 24781082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
